Related Experiment Videos
Clinically significant drug interactions in dermatology
1Department of Dermatology, University of Oklahoma Health Sciences Center, Tulsa, USA.
Journal of the American Academy of Dermatology
|April 29, 1998
Summary
Finding clinically significant drug interactions is difficult, causing uncertainty for healthcare providers. This study discusses drug interaction pharmacology, highlighting common hepatic metabolism alterations and identifying "red flag" drugs for dermatologists.
Area of Science:
- Pharmacology
- Drug Interactions
- Dermatology
Background:
- Clinically significant drug interaction information is not readily accessible, leading to uncertainty and time-consuming searches.
- Drug interactions often involve altered hepatic metabolism, a key area of pharmacological study.
- Identifying high-risk medications is crucial for patient safety.
Purpose of the Study:
- To address the lack of accessible information on clinically significant drug interactions.
- To discuss the pharmacology of common drug interactions, particularly those affecting hepatic metabolism.
- To provide dermatologists with a comprehensive list of significant drug interactions relevant to their practice.
Main Methods:
- Review of pharmacological literature on drug interactions.
- Identification of drugs frequently involved in significant interactions.
- Compilation of a categorized list of drug interactions pertinent to dermatology.
Main Results:
- Common drug interactions frequently involve altered hepatic metabolism.
- At least 26 drugs are identified as "red flag" medications due to frequent interactions.
- An extensive list of significant and less significant drug interactions for dermatologists is presented.
Conclusions:
- Improved accessibility to drug interaction data is needed.
- Understanding hepatic metabolism is key to managing drug interactions.
- The provided list serves as a valuable resource for dermatologists to mitigate risks associated with drug interactions.